Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain

Food and Chemical Toxicology

Volumn 49, Issue 11, 2011, Pages 2906-2913

  Kakkar, Vandita ^a   Kaur, Indu Pal ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Aluminium chloride; Alzheimer's; Bioavailable; Curcumin; Solid lipid nanoparticles

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; CURCUMIN; MEMBRANE LIPID; RIVASTIGMINE; SOLID LIPID NANOPARTICLE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; BRAIN TISSUE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SCREENING; HISTOPATHOLOGY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; RECOMMENDED DRUG DOSE; TREATMENT RESPONSE;

ACETYLCHOLINESTERASE; ALUMINUM COMPOUNDS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHLORIDES; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPIDS; MALE; MAZE LEARNING; MICE; NANOPARTICLES;

MUS;

EID: 80052839510     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.08.006     Document Type: Article

References (90)

1. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009, 41:40-59.
2. Anand P., Nair H.B., Sung B., Kunnumakkara A.B., Yadav V.R., Tekmal R.R., Aggarwal B.B. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 2010, 79:330-338.
3. Banks W.A., Kastin A.J. Aluminum induced neurotoxicity: alteration in membrane function at the blood-brain barrier. Neurosci. Biobehav. Rev. 1989, 13:47-53.
4. Baum L., Cheung S.K.K., Mok V.C.T., Lam L.C.W., Leung V.P.Y., Hui E., Ng C.C.Y., Chow M., Ho P.C., Lam S., Woo J., Chiu H.F.K., Goggins W., Zee B., Wong A., Mok H., Cheng W.K.F., Fong C., Lee J.S.W., Chan M.-H., Szeto S.S.L., Lui V.W.C., Tsoh J., Kwok T.C.Y., Chan I.H.S., Lam C.W.K. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol. Res. 2007, 56:509-514.
5. Bharathi P., Shamasundar N.M., Sathyanarayana R.T.S., Naidu M.D., Ravid R., Rao K.S.J. A new insight on Al-maltolatetreated aged rabbits as Alzheimer's animal model. Brain Res. Rev. 2006, 52:275-292.
6. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A. Polymeric nanoparticle-encapsulated curcumin (" nanocurcumin" ): a novel strategy for human cancer therapy. J. Nanobiotechnol. 2007, 5:3.
7. Bondy S.C., Guo-Ross S.X., Pien J. Mechanisms underlying the aluminum-induced potentiation of the pro-oxidant properties of transition metals. Neurotoxicology 1998, 19:65-71.
8. Calabrese E.J., Baldwin L.A. Defining hormesis. Hum. Exp. Toxicol. 2002, 21:91-97.
9. Calabrese V., Bates T.E., Mancuso C., Cornelius C., Ventimiglia B., Cambria M.T., Di Renzo L., De Lorenzo A., Dinkova-Kostova A.T. Curcumin and the cellular stress response in free radical-related diseases. Mol. Nutr. Food Res. 2008, 52:1062-1073.
10. Candy J.M., Oakley A.E., Klinowski J., Carpenter T.A., Perry R.H., Atack J.R. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1986, 1:354-357.
11. Claiborne, A., 1985. Catalase activity. In: Greenwald, R.A. (Ed.), Handbook of Methods for Oxygen Radical Research. CRC Press, pp. 283-284.
12. Cole G.M., Teter B., Frautschy S.A. Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 2007, 595:197-212.
13. Cummings J.L., Vinters H.V., Cole G.M., Khachaturian Z.S. Alzheimer's disease etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998, 51:S2-S17.
14. Deloncle R., Huguet E., Fernandez B., Quellard N., Babin P.H., Guillard O. Ultrastructural study of rat hippocampus after chronic administration of aluminium l-glutamate: an acceleration of aging process. Exp. Gerontol. 2001, 36:234-244.
15. Domingo J.L. Reproductive and developmental toxicity of aluminum: a review. Neurotoxicol. Teratol. 1995, 17:515-521.
16. Ellman G.L., Courtney K.D. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-90.
17. Exley C. Aluminum and Alzheimer's disease. J. Alzheimers Dis. 2001, 3:551-552.
18. Exley C. The pro-oxidant activity of aluminum. Free Rad. Biol. Med. 2004, 36:380-387.
19. Florence A.l., Gauthier A., Ponsar C., Van den B., Chichton R.R. An experimental animal model of aluminum overload. Neurodegeneration 1994, 3:315-323.
20. Frautschy S.A., Hu W. Phenolic anti inflammatory antioxidant reversal of b induced cognitive deficits and neuropathology. Neurobiol. Aging 2001, 22:993-1005.
21. Fridovick I. Superoxide radical: an endogenous toxicant. Ann. Rev. Pharmacol. Toxicol. 1975, 23:239-253.
22. Friedlich A.L., Butcher L.L. Involvement of free oxygen radicals in B-amyloidosis: an hypothesis. Neurobiol. Aging 1994, 15:443-455.
23. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P.C.B. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995, 373:523-527.
24. Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007, 102:1095-1104.
25. García T., Ribes D., Teresa M., Cabré Colomina M., Domingo L., Gómez M. Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease. Toxicology 2009, 265:49-55.
26. Golub M.S., Han B., Keen C.L. Aluminum uptake and effects on transferrin mediated iron uptake in primary cultures of rat neurons, astrocytes and oligodendrocytes. Neurotoxicology 1999, 20:961-970.
27. Gulya K., Rakonczay Z., Kasa P. Cholinotoxic effects of aluminium in rat brain. J. Neurochem. 1990, 54:1020-1026.
28. Johnson G.V., Jope R.S. Aluminum impairs glucose utilization and cholinergic activity in rat brain in vitro. Toxicology 1986, 40:93-102.
29. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Int. J. Clin. Exp. Pharmacol. 1974, 11:151-169.
30. Jyoti A., Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology 2006, 27:451-457.
31. Kakkar V., Kaur I.P. Evolving the concept of curcumin as a neurohormetic. Pharmacos 2011, 37:25-28.
32. Kakkar V., Singh S., Singla D., Kaur I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nut. Food Res. 2011, 55:495-503.
33. Kaur I.P., Bhandari R., Bhandari S., Kakkar V. Potential of solid lipid nanoparticles for brain targeting. J. Control. Release 2008, 127:97-109.
34. Kawahara M., Kato-Negishi M., Hosoda R. Brain derived neurotrophic factor protects cultured rat hippocampal neurons from aluminium maltolate neurotoxicity. J. Inorg. Biochem. 2003, 97:124-131.
35. Kawahara M., Kato M., Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 2001, 55:211-217.
36. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189-195.
37. Koudinov A.R., Koudinova N.V. Modulation of cholesterol metabolism initiates Alzheimer's amyloid deposition and neuronal dysfunction. Soc. Neurosci. Abstr. 2000, 26:497.
38. Lepara O., Valjevac A., Alajbegović A., Zaćiragić A., Nakas-Ićindić E. Decreased serum lipids in patients with probable Alzheimer's disease. Bosn. J. Basic Med. Sci. 2009, 9:215-220.
39. Li H.L., Zhao X.B., Ma Y.K., Zhai G.X., Li L.B., Lou H.X. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 2009, 133:238-244.
40. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
41. Llobet J.M., Domingo J.L., Gómez M., Tomás J.M., Corbella J. Acute toxicity studies of aluminium compounds: antidotal efficacy of several chelating agents. Pharmacol. Toxicol. 1987, 60:280-283.
42. Luo Y.F., Chen D.W., Ren L.X., Zhao X.L., Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 2006, 114:53-59.
43. Ma Q.-L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., Chen P.P., Hudspeth B., Chen C., Zhao Y., Vinters H.V., Frautschy S.A., Cole G.M. Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun n-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 2009, 29:9078-9089.
44. Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330:155-163.
45. Mancuso C., Barone E. Curcumin in clinical practice. myth or reality?. Trends Pharmacol. Sci. 2009, 30:333-334.
46. Mancuso C., Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr. Drug Metab. 2009, 10:579-594.
47. Mancuso C., Bates T.E., Butterfield D.A., Calafato S., Cornelius C., De Lorenzo A., Dinkova K., Albena T., Calabrese V. Natural antioxidants in Alzheimer's disease. Expert. Opin. Investig. Drugs 2007, 16:1921-1931.
48. McLaughlin A., Kazantzis G., King E., Teare D., Porter R.J., Owen R. Pulmonary fibrosis and encephalopathy associated with the inhalation of AlCl3 dust. Br. J. Ind. Med. 1962, 19:253-263.
49. Miu A.C., Benga O. Aluminum and Alzheimer's disease: a new look. J. Alzheimers Dis. 2006, 10:179-201.
50. Montine T.J., Markesbery W.R., Zackert W., Sanchez S.C., Roberts L.J., Morrow J.D. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with ApoE genotype in Alzheimer's disease patients. Am. J. Pathol. 1999, 155:863-868.
51. Morris R.G.M., Garrud P., Rawlins J.N.P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
52. Nehru B., Anand P. Oxidative damage following chronic aluminium exposure in adult and pup rat brains. J. Trace Elem. Med. Biol. 2005, 19:203-208.
53. Newairy A.-S.A., Salama A.F., Hussien H.M., Yousef M.I. Propolis alleviates aluminium-induced lipid peroxidation and biochemical parameters in male rats. Food Chem. Toxicol. 2009, 47:1093-1098.
54. Oteiza P.I., Fraga C.G., Keen C.L. Aluminum has both oxidant and antioxidant effects in mouse brain membranres. Arch. Biochem. Biophys. 1993, 300:517-521.
55. Pepeu G., Giovannelli L., Casamenti F., Scali C., Bartolini L. Amyloid β-peptides injection into the cholinergic nuclei: morphological, neurochemical and behavioral effects. Prog. Brain Res. 1996, 109:273-282.
56. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991, 563:311-314.
57. Platt B., Carpenter C., Busselberg D., Reymann K.G., Riedel G. Aluminium impairs hippocampal long term potentiation in rats in vitro and in vivo. Exp. Neurol. 1995, 134:73-86.
58. Platt B., Fiddler G., Riedel G., Henderson Z. Aluminum toxicity in the rat brain: histochemical and immunocytochemical evidences. Brain Res. Bull. 2001, 55:257-267.
59. Ravi S.M., Prabhu B.M., Raju T.R., Bindu P.N. Long term effects of post natal aluminium exposure on acetylcholinesterase activity and biogenic amine neurotransmitters in rat brain. Indian J. Physiol. Pharmacol. 2000, 44:473-478.
60. Rebai O., Djebli N.E. Chronic exposure to aluminum chloride in mice: exploratory behaviors and spatial learning. Adv. Biol. Res. 2008, 2:26-33.
61. Reyes A.E., Perez D.R., Alvarez A., Garrido J., Gentry M.K., Doctor B.P., Inestrosa N.C. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem. Biophys. Res. Commun. 1997, 232:652-655.
62. Rui P., Sheng Q., Da-xiang L., Jun D. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice. Chin. Med. J. 2008, 121:832-839.
63. Sakamoto T., Ogasawara Y., Ishii K., Takahashi H.S.T. Accumulation of aluminium in ferritin isolated from rat brain. Neurosci. Lett. 2004, 336:264-267.
64. 3-induced neurodegeneration: increased susceptibility with aging. Neurotoxicol 1999, 20:805-817.
65. Selkoe D.J. The origins of Alzheimer's disease: a is for amyloid. JAMA 2000, 283:1615-1617.
66. Sethi P., Jyoti A., Hussain E., Sharma D. Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol. Biochem. Behav. 2009, 93:31-39.
67. Sethi P., Jyoti A., Singh R., Hussain E., Sharma D. Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 2008, 29:1069-1079.
68. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998, 353:356.
69. Shukitt-Hale B., Erat S.A., Joseph J.A. Spatial learning and memory deficits induced by dopamine administration with decreased glutathione. Free Radic. Biol. Med. 1998, 24:1149-1158.
70. Simoni E., Bergamini C., Fato R., Tarozzi A., Bains S., Motterlini R., Cavalli A., Bolognesi M.L., Minarini A., Hrelia P., Lenaz G., Rosini M., Melchiorre C. Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents. J. Med. Chem. 2010, 53:7264-7268.
71. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 1997, 17:2653-2657.
72. Spillantini M.G., Goedert M. The protein pathology in neurodegenerative diseases. Trends Neurosci. 1998, 21:428-433.
73. Standaert D.G., Young A.B. Treatment of central nervous system. Degenerative disorders 2001, McGraw-Hill, New York.
74. Suarez-Fernandez M.B., Soldado A.B., Sanz-Mendel A., Vega J.A., Novelli A., Fernandez-Sanchez M.T. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res. 1999, 835:125-136.
75. Sugawara C., Sugawara N., Kiyosawa H., Miyake H. Decrease of serum triglyceride in normal rats fed with 2000ppm aluminum diet for 67 days. I: Feeding young rats sucrose, lactose, milk, casein or soy-protein diets with addition of aluminum chloride. Fundam. Appl. Toxicol. 1988, 10:607-615.
76. Sugiyama Y., Kawakishi S., Osawa T. Involvement of the [beta]-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol. 1996, 52:519-525.
77. Tiyaboonchai W., Tungpradit W., Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 2007, 337299:306.
78. Tsai Y.-M., Jan W.-C., Chien C.-F., Lee W.-C., Lin L.-C., Tsai T.-H. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011, 127:918-925.
79. Tuzcu M., Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur. J. Pharmacol. 2006, 537:106-110.
80. Van der Staay F.J., de Jonge M. Effects of age on water escape behavior and on related acquisition in rats. Behav. Neural Biol. 1993, 60:33-41.
81. 3+-mediated lipid oxidation: effect of galactolipids. Arch. Biochem. Biophys. 1994, 308:374-379.
82. Walton J.R. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J. Inorg. Biochem. 2007, 101:1275-1284.
83. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 1966, 99:667-678.
84. Xu N., Majidi V., Markesbery W.R., Ehmann W.D. Brain aluminum in Alzheimer's disease using an improved GFAAS method. Neurotoxicology 1992, 13:735-744.
85. Yamada K., Fuji K., Nabeshima T., Kameyama T. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats. Neurosci. Lett. 1990, 118:128-131.
86. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.
87. Yoshino, M., Ito, M., Haneda, M., Tsubouchi, R., Murakami, K., 1999. Prooxidant action of aluminum ion - stimulation of iron-mediated lipid peroxidation by aluminum. Biometals 12, 237-240.
88. Yousef M.I., El-Morsy A.M.A., Hassan M.S. Aluminium-induced deterioration in reproductive performance and seminal plasma biochemistry of male rabbits: protective role of ascorbic acid. Toxicology 2005, 215:97-107.
89. Zatta P., Ibn-Lkhayat-Idrissi M., Zambenedetti P., Kilyen M., Kiss T. In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res. Bull. 2002, 59:41-45.
90. Zatta P., Zambenedetti P., Bruna V., Filippi B. Activation of acetylcholinesterase by aluminium(III): the relevance of the metal species. Neuroreport 1994, 5:1777-1780.